FDA has raised regulatory and safety concerns regarding certain BPC-157-related bulk substances used in compounding contexts, and FDA has historically taken enforcement action against compounded BPC-157 preparations marketed for therapeutic injection
Measure hematologic parameters on an annual basis and vitamin B12 measurements at 2- to 3-year intervals in patients on JANUMET XR and manage any abnormalities [see ADVERSE REACTIONS ]
They reduce systemic inflammation , improve adipokine balance, and restore gut barrier function [24] Better pain and physical-function outcomes in osteoarthritis, and reduced flares in patients with rheumatoid arthritis on DMARDs, pointing to dual cardiometabolic and anti-inflammatory benefits.[28][42] Overall, the integration of GLP-1RA into the treatment of autoimmune diseases has yielded partial improvements in disease control and significant benefits in managing metabolic comorbidities. This does not remove the requirement for standard immunotherapies
So far, clinical trials havent resulted in regulatory approval, and pharmaceutical companies havent been motivated to invest in further development
The clinical data is clear that meaningful appetite suppression begins at 4mg and above
